PRIDECORT (Tablet)

PRIDECORT is a high-potency tablet formulation containing Deflazacort 6 mg.

Composition: Deflazacort 6 mg
Dosage Form: Tablet

Clinical Pharmacology

Deflazacort is a glucocorticoid with anti-inflammatory and immunosuppressive activity.

Indications & Usage

Depending on the clinical indication, corticosteroid therapy may be used in:

• Inflammatory rheumatologic conditions
• Autoimmune disorders
• Allergic/inflammatory conditions
• Selected dermatological inflammatory disorders
• Other corticosteroid-responsive conditions

Contraindications

• Hypersensitivity
• Untreated systemic infections where corticosteroid therapy is inappropriate
• Certain live-vaccine situations during immunosuppressive therapy

Warnings & Precautions

Long-term therapy may cause adrenal suppression, infection risk, hyperglycemia, osteoporosis, hypertension and other corticosteroid-related effects. Do not discontinue prolonged therapy abruptly.

Drug Interactions

NSAIDs, antidiabetic medicines, anticoagulants, vaccines, CYP3A4-inducing/inhibiting medicines and other immunosuppressants.

Pregnancy & Lactation

Use only when clearly indicated and under medical supervision.

Dosage & Administration

Dose varies substantially according to disease and clinical response. Follow the physician’s prescribed tapering schedule.

Adverse Reactions

Increased appetite, weight gain, hyperglycemia, hypertension, dyspepsia, mood changes, fluid retention and increased susceptibility to infection.

Therapeutic Focus: Corticosteroid / Anti-inflammatory | Primary Specialty: Pain Management